Aurobindo receives Tentative approval for Quinapril Hydrochloride & Hydrochlorothiazide Tablets from USFDA

Aurobindo Pharma Ltd has announced that the Company has received tentative approval from the USFDA for Quinapril Hydrochloride and Hydrochlorothiazide Tablets 10mg/12.5mg, and 20mg/25mg. With this the Company's product basket for the USA market has gone up to Forty five.

This is indicated for the treatment of Hypertension.

Quinapril Hydrochloride and Hydrochlorothiazide Tablets 10mg/12.5mg, 20mg/12.5mg and 20mg/25mg is the Generic equivalent of ACCURETIC^TM Tablets (Pfizer Pharmaceuticals Ltd.,). This is the fifth Anti hypertensive (Medicines regulating blood pressure) of the Company bagging USFDA's nod.

The stock was trading at Rs.788.05, down by Rs.3.85 or 0.49%. The stock hit an intraday high of Rs.798 and low of Rs.768.10. The total traded quantity was 23890 compared to 2 week average of 67807.

Source : Equity Bulls

Keywords